BIO Integration

Compuscript Ltd

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

BIO Integration is an open-access journal published by Compuscript Ltd in Ireland, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 17 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Compuscript Ltd
ISSN
2712-0074 · 2712-0082
Country
Ireland
Languages
english
Access
Open access
Articles in DOAJ
209
Declared review time
17 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2021-07-06
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
17 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

209

Most recent article

last month

Average review time (journal-declared via DOAJ)

17weeks

Works in OpenAlex

202

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

22

i10-index

42

From OpenAlex open data (CC0).

Editorial & policy10
Last DOAJ review date
2026-09-18
Added to DOAJ
2021-07-06
Declared plagiarism screening
Declared
Other fees beyond APC
No
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Editorial board
Official page ↗
Open references deposited at Crossref
98%
ORCID iDs in current deposits
12%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • Nanoparticle-Based Drug Delivery
  • Nanoplatforms for cancer theranostics
  • Nanoplatforms for cancer theranostics
  • Nanoplatforms for cancer theranostics
  • Ultrasound and Hyperthermia Applications
  • Advanced Drug Delivery Systems
  • Ultrasound and Hyperthermia Applications
  • Ultrasound and Hyperthermia Applications
Show all subjects (75)
  • RNA Interference and Gene Delivery
  • Interdisciplinary Research and Collaboration
  • Biomedical and Engineering Education
  • RNA Interference and Gene Delivery
  • Nanoparticle-Based Drug Delivery
  • Nanoparticle-Based Drug Delivery
  • Biomedical and Engineering Education
  • RNA Interference and Gene Delivery
  • 3D Printing in Biomedical Research
  • Artificial Intelligence in Healthcare and Education
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • 3D Printing in Biomedical Research
  • MicroRNA in disease regulation
  • Bone Tissue Engineering Materials
  • Medicinal Plant Research
  • Extracellular vesicles in disease
  • Drug Solubulity and Delivery Systems
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • Bone Tissue Engineering Materials
  • Cancer Immunotherapy and Biomarkers
  • COVID-19 Clinical Research Studies
  • Artificial Intelligence in Healthcare and Education
  • Drug Solubulity and Delivery Systems
  • Research, Science, and Academia
  • COVID-19 Clinical Research Studies
  • Artificial Intelligence in Healthcare and Education
  • Mesenchymal stem cell research
  • Drug Solubulity and Delivery Systems
  • Advancements in Transdermal Drug Delivery
  • Advanced biosensing and bioanalysis techniques
  • Immunotherapy and Immune Responses
  • Liver Disease Diagnosis and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Nanoparticles: synthesis and applications
  • Radiomics and Machine Learning in Medical Imaging
  • Liver Disease Diagnosis and Treatment
  • Ferroptosis and cancer prognosis
  • Tissue Engineering and Regenerative Medicine
  • SARS-CoV-2 and COVID-19 Research
  • Cancer-related molecular mechanisms research
  • Genetic Associations and Epidemiology
  • Advanced biosensing and bioanalysis techniques
  • Cancer-related molecular mechanisms research
  • AI in cancer detection
  • Computational Drug Discovery Methods
  • Bone Tissue Engineering Materials
  • Photoacoustic and Ultrasonic Imaging
  • Extracellular vesicles in disease
  • Ferroptosis and cancer prognosis
  • Immune cells in cancer
  • Hydrogels: synthesis, properties, applications
  • Hydrogels: synthesis, properties, applications
  • Virus-based gene therapy research
  • Advanced Drug Delivery Systems
  • Virus-based gene therapy research
  • Advanced Drug Delivery Systems
  • Natural Antidiabetic Agents Studies
  • Ultrasound Imaging and Elastography
  • Diabetes Treatment and Management
  • Immune cells in cancer
  • Metabolomics and Mass Spectrometry Studies
  • Diabetes Treatment and Management
  • Antimicrobial Peptides and Activities
  • Ultrasound Imaging and Elastography
  • Antimicrobial Peptides and Activities

Keywords (DOAJ)

  • biosciences
  • medicine
  • biochemistry
  • biophysics
  • bioengineering
  • biotechnology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: